Dc Funds, L.P. is an investment fund managing more than $10.3 billion ran by Dean Ii. There are currently 3 companies in Mr. Ii’s portfolio. The largest investments include Tscan Therapeutics Inc and Werewolf Therapeutics Inc, together worth $8.82 billion.
As of 7th May 2024, Dc Funds, L.P.’s top holding is 630,000 shares of Tscan Therapeutics Inc currently worth over $5 billion and making up 48.3% of the portfolio value.
In addition, the fund holds 589,102 shares of Werewolf Therapeutics Inc worth $3.82 billion.
The third-largest holding is Barinthus Biotherapeutics Pl worth $1.53 billion.
Currently, Dc Funds, L.P.'s portfolio is worth at least $10.3 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Dc Funds, L.P. office and employees reside in Mclean, Virginia. According to the last 13-F report filed with the SEC, Dean Ii serves as the Managing Director and CEO at Dc Funds, L.P..
The two most similar investment funds to Dc Funds, L.P. are Sei Trust Co and Osmium Partners. They manage $10.3 billion and $10.4 billion respectively.
These positions were updated on May 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Tscan Therapeutics Inc |
No change
630,000
|
$5,002,200,000 | 48.34% |
| Werewolf Therapeutics Inc |
No change
589,102
|
$3,817,381,000 | 36.89% |
| Barinthus Biotherapeutics Pl |
No change
642,204
|
$1,528,446,000 | 14.77% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||